livehealth.store

Stason Pharmaceuticals recalls

Stason Pharmaceuticals has 2 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 13 Mar 2024. The most frequent reason is potency & assay.

Total recalls2since 2016

Last 12 months0reported

Class I00% of total

Ongoing0latest 13 Mar 2024

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 2 100%

Why stason pharmaceuticals is recalled

Potency & Assay2100%

By year

2024150%
2016150%

All stason pharmaceuticals recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
13 Mar 2024Drug	CLASS III	Mercaptopurine Tablets, USP 50 mg recalled by Stason Pharmaceuticals	Stason Pharmaceuticals	Potency & Assay	Nationwide
14 Sep 2016Drug	CLASS III	Selegiline HCL Tablets USP 5mg recalled by Stason Pharmaceuticals	Stason Pharmaceuticals	Potency & Assay	NC

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.